Danielle Antalffy
Stock Analyst at UBS
(3.44)
# 2,309
Out of 4,512 analysts
603
Total ratings
50.5%
Success rate
2.3%
Average return
Main Sectors:
Stocks Rated by Danielle Antalffy
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ABT Abbott Laboratories | Reiterated: Buy | $158 → $135 | $88.96 | +51.75% | 38 | Apr 20, 2026 | |
| BSX Boston Scientific | Rated: Buy | $120 → $105 | $42.63 | +146.31% | 42 | Mar 17, 2026 | |
| ISRG Intuitive Surgical | Rated: Hold | $570 → $550 | $379.50 | +44.93% | 10 | Mar 17, 2026 | |
| JNJ Johnson & Johnson | Rated: Buy | $214 → $280 | $253.85 | +10.30% | 34 | Mar 17, 2026 | |
| SYK Stryker | Rated: Hold | $400 → $380 | $311.07 | +22.16% | 20 | Mar 17, 2026 | |
| SGHT Sight Sciences | Rated: Buy | $12 → $11 | $5.05 | +117.82% | 6 | Mar 6, 2026 | |
| TMCI Treace Medical Concepts | Maintained: Hold | $2.5 → $2.25 | $4.44 | -49.32% | 15 | Mar 2, 2026 | |
| PRCT PROCEPT BioRobotics | Maintained: Buy | $62 → $30 | $19.31 | +55.36% | 9 | Mar 2, 2026 | |
| RXST RxSight | Maintained: Hold | $8 → $9 | $4.92 | +82.93% | 11 | Feb 26, 2026 | |
| TNDM Tandem Diabetes Care | Maintained: Hold | $17 → $22 | $15.54 | +41.57% | 27 | Feb 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $400 | $159.12 | +151.38% | 43 | Feb 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $58 → $55 | $34.32 | +60.26% | 26 | Feb 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $16.86 | +42.35% | 2 | Feb 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $104 | $79.30 | +31.15% | 40 | Feb 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $21 → $19 | $21.80 | -12.84% | 26 | Feb 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $95 | $74.12 | +28.17% | 40 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $89 → $67 | $49.15 | +36.32% | 21 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $94 → $90 | $90.09 | -0.10% | 42 | Feb 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $86 → $89 | $91.03 | -2.23% | 18 | Feb 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $24 | $18.21 | +31.80% | 1 | Feb 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $145 → $150 | $152.45 | -1.61% | 4 | Jan 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $57 → $50 | $24.65 | +102.84% | 3 | Jan 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $16 → $16 | $14.92 | +7.24% | 8 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $2.25 | $7.75 | n/a | 1 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 | $102.37 | n/a | 10 | May 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 | $15.84 | n/a | 11 | May 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 | $2.34 | n/a | 6 | May 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 | $5.76 | n/a | 5 | May 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $275 | $150.65 | n/a | 6 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $65 → $55 | $4.54 | n/a | 10 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 | $46.09 | n/a | 14 | May 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 → $14 | $38.77 | n/a | 6 | May 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $5 | $0.3885 | n/a | 14 | May 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $6.33 | n/a | 20 | Jan 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $2 → $3 | $5.03 | n/a | 14 | Aug 9, 2021 |
Abbott Laboratories
Apr 20, 2026
Reiterated: Buy
Price Target: $158 → $135
Current: $88.96
Upside: +51.75%
Boston Scientific
Mar 17, 2026
Rated: Buy
Price Target: $120 → $105
Current: $42.63
Upside: +146.31%
Intuitive Surgical
Mar 17, 2026
Rated: Hold
Price Target: $570 → $550
Current: $379.50
Upside: +44.93%
Johnson & Johnson
Mar 17, 2026
Rated: Buy
Price Target: $214 → $280
Current: $253.85
Upside: +10.30%
Stryker
Mar 17, 2026
Rated: Hold
Price Target: $400 → $380
Current: $311.07
Upside: +22.16%
Sight Sciences
Mar 6, 2026
Rated: Buy
Price Target: $12 → $11
Current: $5.05
Upside: +117.82%
Treace Medical Concepts
Mar 2, 2026
Maintained: Hold
Price Target: $2.5 → $2.25
Current: $4.44
Upside: -49.32%
PROCEPT BioRobotics
Mar 2, 2026
Maintained: Buy
Price Target: $62 → $30
Current: $19.31
Upside: +55.36%
RxSight
Feb 26, 2026
Maintained: Hold
Price Target: $8 → $9
Current: $4.92
Upside: +82.93%
Tandem Diabetes Care
Feb 20, 2026
Maintained: Hold
Price Target: $17 → $22
Current: $15.54
Upside: +41.57%
Feb 19, 2026
Reiterated: Buy
Price Target: $400
Current: $159.12
Upside: +151.38%
Feb 18, 2026
Maintained: Buy
Price Target: $58 → $55
Current: $34.32
Upside: +60.26%
Feb 18, 2026
Reiterated: Buy
Price Target: $24
Current: $16.86
Upside: +42.35%
Feb 17, 2026
Maintained: Hold
Price Target: $104
Current: $79.30
Upside: +31.15%
Feb 16, 2026
Maintained: Hold
Price Target: $21 → $19
Current: $21.80
Upside: -12.84%
Feb 13, 2026
Reiterated: Buy
Price Target: $95
Current: $74.12
Upside: +28.17%
Feb 13, 2026
Maintained: Hold
Price Target: $89 → $67
Current: $49.15
Upside: +36.32%
Feb 12, 2026
Maintained: Hold
Price Target: $94 → $90
Current: $90.09
Upside: -0.10%
Feb 11, 2026
Maintained: Sell
Price Target: $86 → $89
Current: $91.03
Upside: -2.23%
Feb 9, 2026
Initiated Coverage: Buy
Price Target: $24
Current: $18.21
Upside: +31.80%
Jan 28, 2026
Maintained: Buy
Price Target: $145 → $150
Current: $152.45
Upside: -1.61%
Jan 5, 2026
Maintained: Buy
Price Target: $57 → $50
Current: $24.65
Upside: +102.84%
Nov 6, 2025
Maintained: Hold
Price Target: $16 → $16
Current: $14.92
Upside: +7.24%
Mar 28, 2023
Initiated Coverage: Hold
Price Target: $2.25
Current: $7.75
Upside: n/a
May 17, 2022
Reiterated: Buy
Price Target: $100
Current: $102.37
Upside: n/a
May 12, 2022
Maintained: Buy
Price Target: $12
Current: $15.84
Upside: n/a
May 10, 2022
Maintained: Buy
Price Target: $13
Current: $2.34
Upside: n/a
May 9, 2022
Maintained: Buy
Price Target: $12
Current: $5.76
Upside: n/a
May 5, 2022
Rated: Hold
Price Target: $275
Current: $150.65
Upside: n/a
May 5, 2022
Rated: Buy
Price Target: $65 → $55
Current: $4.54
Upside: n/a
May 4, 2022
Reiterated: Buy
Price Target: $45
Current: $46.09
Upside: n/a
May 4, 2022
Reiterated: Buy
Price Target: $12 → $14
Current: $38.77
Upside: n/a
May 3, 2022
Rated: Buy
Price Target: $5
Current: $0.3885
Upside: n/a
Jan 10, 2022
Maintained: Hold
Price Target: n/a
Current: $6.33
Upside: n/a
Aug 9, 2021
Reiterated: Hold
Price Target: $2 → $3
Current: $5.03
Upside: n/a